Riskpilot← Back to searchSign inGet full accessEB-R NeuroRe AB
ABDissolvedOrg 5565065348General medical practice activities · NACE 8621Est. 19950 employees
Revenue 2021
SEK 0
EBITDA margin
—
0% vs 2020
Equity ratio
84.1%
Financial strength
Net profit 2021
SEK -70K
0% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -70K | +0% |
| Net profit | SEK -70K | +0% |
| Total assets | SEK 107K | -61% |
| Equity | SEK 90K | -65% |
| Employees | 0 | — |
Legal name
EB-R NeuroRe AB
Org number
5565065348
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 januari 1995
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget skall bedriva privatpraktik samt konsult- och utbildningsverksamhet för sjukgymnastisk verksamhet ävensom idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 426 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 576 | −76 | −73 | −70 | −70 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 576 | −76 | −73 | −70 | −70 |
| Net financials | 13 | — | — | — | — |
| Profit before tax | 612 | 11 | −42 | −70 | −70 |
| Tax | −139 | −3 | −0 | −0 | −0 |
| Net profit | 473 | 8 | −42 | −70 | −70 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 898 | 679 | 450 | 273 | 107 |
| Equity | 665 | 573 | 431 | 260 | 90 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 115 | 75 | 20 | 13 | 17 |
| Total debt | 115 | 75 | 20 | 13 | 17 |
EBITDA margin
-7000000.0%
This company
15.8%
Market median
-44303897% vs market
20172021
Equity ratio
84.1%
This company
38.2%
Market median
+120% vs market
20172021
Return on equity
-77.8%
This company
18.4%
Market median
-523% vs market
20172021
Net profit margin
-7000000.0%
This company
8.1%
Market median
-86419853% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EB-R NeuroRe AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Gustav Andersson | Deputy Board Member | 0 companies |
| Inger Margareta Dahle | Deputy Board Member | 0 companies |
| Eva Kristin Bramell Risberg | Board of Directors | 0 companies |
| Barbro Elisabeth Hansson | Deputy Board Member | 0 companies |
| Bengt Junior Niklas Nygårds | Deputy Board Member | 0 companies |
| Ulrika Margareta Ahlholm | Board of Directors | 0 companies |
| Lars Mårten Risberg | Deputy Board Member | 0 companies |